Literature DB >> 31888957

A Bicistronic Plasmid Encoding Brain-Derived Neurotrophic Factor and Urokinase Plasminogen Activator Stimulates Peripheral Nerve Regeneration After Injury.

Maxim Karagyaur1, Alexandra Rostovtseva2, Ekaterina Semina2, Polina Klimovich2, Vadim Balabanyan2, Pavel Makarevich2, Vladimir Popov2, Dmitry Stambolsky2, Vsevolod Tkachuk2.   

Abstract

Timely nerve restoration is an important factor for the successful regeneration of tissues and organs. It is known that axon regeneration following nerve injury is a multifactorial process that depends on the local expression of neurotrophins, including brain-derived neurotrophic factor (BDNF). Along with the survival of neurons, the active reorganization of the extracellular matrix is an important step for the growth of axons to their targets. Urokinase serine protease is part of the plasminogen activator system, which provides the vectoriality of the process of fibrinolysis and matrix reorganization, facilitating the growth of nerves to their targets. Based on this and in view of the results of our previous studies, we suggest that a combined bicistronic plasmid encoding the complementary proteins BDNF and urokinase may be beneficial in nerve regeneration. The ability of this bicistronic plasmid to stimulate nerve restoration was confirmed by in vitro stimulation of Neuro2a neurite growth and in vivo nerve conductivity and histology studies. To our knowledge, this is the first article that demonstrates the effectiveness of a bicistronic plasmid containing the human genes BDNF and urokinase plasminogen activator in the regeneration of the injured peripheral nerve. The results obtained demonstrate that plasmid vectors encoding several complementary-active therapeutic proteins may serve as a basis for developing prospective treatments for a wide range of multicomponent neural system disorders, such as nerve trauma. SIGNIFICANCE STATEMENT: This study is the first to show the effectiveness of using a bicistronic plasmid encoding complementary-active human protein brain-derived neurotrophic factor and urokinase plasminogen activator in the regeneration of the crushed peripheral nerve in a murine model.
Copyright © 2020 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31888957     DOI: 10.1124/jpet.119.261594

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Urokinase-Type Plasminogen Activator Enhances the Neuroprotective Activity of Brain-Derived Neurotrophic Factor in a Model of Intracerebral Hemorrhage.

Authors:  Stalik Dzhauari; Svetlana Litvinova; Anastasia Efimenko; Natalia Aleksandrushkina; Nataliya Basalova; Maxim Abakumov; Natalia Danilova; Pavel Malkov; Vadim Balabanyan; Tatiana Bezuglova; Viktor Balayants; Maxim Mnikhovich; Mikhail Gulyaev; Mariya Skryabina; Vladimir Popov; Dmitry Stambolsky; Tatiana Voronina; Vsevolod Tkachuk; Maxim Karagyaur
Journal:  Biomedicines       Date:  2022-06-08

Review 2.  Basic mechanisms of peripheral nerve injury and treatment via electrical stimulation.

Authors:  Xiao-Lei Chu; Xi-Zi Song; Qi Li; Yu-Ru Li; Feng He; Xiao-Song Gu; Dong Ming
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

3.  A Novel Cre/lox71-Based System for Inducible Expression of Recombinant Proteins and Genome Editing.

Authors:  Maxim Karagyaur; Daniyar Dyikanov; Pyotr Tyurin-Kuzmin; Stalik Dzhauari; Mariya Skryabina; Maksim Vigovskiy; Alexandra Primak; Natalia Kalinina; Vsevolod Tkachuk
Journal:  Cells       Date:  2022-07-07       Impact factor: 7.666

Review 4.  New Frontiers in Peripheral Nerve Regeneration: Concerns and Remedies.

Authors:  Polina Klimovich; Kseniya Rubina; Veronika Sysoeva; Ekaterina Semina
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.